http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a32889226cd7113f0098af98a5809b9c
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Altevogt |
| name | Peter Altevogt |
| given-name | Peter |
| organization-name | Skin Cancer Unit, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karls University of Heidelberg, 68135 Mannheim, Germany 5Tumor Immunology Programme, D010, German Cancer Research Center, Heidelberg, Germany; and Skin Cancer Unit German Cancer Research Center (DKFZ) 69120 Heidelberg Germany; Department of Dermatology, Venereology and Allergology University Medical Center Mannheim, Ruprecht‐Karl University of Heidelberg 68167 Mannheim Germany Translational Immunology, D015, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Federal Republic of Germany German Cancer Research Center, D-69120 Heidelberg, Germany Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany 4Tumor Immunology Programme, D010 German Cancer Research Center, Heidelberg, Germany Tumor Immunology Programme, 0710, German Cancer Research Center, D-69120 Heidelberg, Germany Tumor Immunology ProgramGerman Cancer Research Center D‐69120 Heidelberg Germany Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim Ruprecht‐Karl University of Heidelberg Mannheim D‐68135 Germany Skin Cancer Unit, German Cancer Research Center (DKFZ) Heidelberg Germany; Department of Dermatology, Venereology and Allergology University Medical Center Mannheim, Ruprecht‐Karl University of Heidelberg Mannheim Germany; Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim University of Heidelberg Mannheim Germany Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg and Dept. of Dermatology, Venereology and Allergology, UMM, University of Heidelberg, Heidelberg, Germany Skin Cancer Unit, German Cancer Research Center, and University Medical Center Mannheim, Germany Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany Department of Translational Immunology, German Cancer Research Center ‡Division of Cellular Immunology, German Cancer Research Center, Heidelberg, Germany 3German Cancer Research Center, Heidelberg, Germany; and 2Translational Immunology, Department of Tumor Immunology, German Cancer Research Center, Heidelberg; Tumor Immunology Programme, D010, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany Tumor Immunology ProgrammeG0100 D‐69120HeidelbergGermany †Tumor Immunology Programme, Cancer Research Center, Heidelberg, Germany Tumor Immunology Programme, D010, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology University Medical Center Mannheim Heidelberg Germany 4D010, German Cancer Research Center, D-69120 Heidelberg, Germany 2Tumor Immunology Programme, D010 German Cancer Research Center, D-69120, Heidelberg, Germany German Cancer Research Center, Department of Translational Immunology, Heidelberg - Germany Skin Cancer Unit German Cancer Research Center (DKFZ) Heidelberg Germany; Department of Dermatology, Venereology and Allergology University Medical Center Mannheim Ruprecht‐Karl University Heidelberg Germany 1Tumor Immunology Programme, D010, German Cancer Research Center; 1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany Translational Immunology, D015, Tumor Immunology Programme German Cancer Research Center (DKFZ) Heidelberg Germany Authors' Affiliations: Departments of 1Obstetrics and Gynecology and 2Radiotherapy, Innsbruck Medical University, Innsbruck, Austria; 3D015-Tumorimmunology, German Cancer Research Center, Heidelberg, Germany; 4Laboratory for Molecular Biology and Cytogenetics, Krankenhaus der Barmherzigen Schwestern Linz, Linz, Austria; and 5Genesis Fertility Center, Patras, Greece 1Skin Cancer Unit, German Cancer Research Center (DKFZ), University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany.; 2Department of Dermatology, Venereology, and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany and Department of Dermatology, Venereology and Allergology University Medical Center Mannheim, Ruprecht‐Karl University of Heidelberg Mannheim Germany 3Tumor Immunology Programme, D010 and D050, German Cancer Research Center, Heidelberg, Germany Authors' Affiliations: 1Tumor Immunology Program, Translational Immunology Unit (D015), German Cancer Research Center, Heidelberg, Germany; 2Department for Pathology, Kaplan Medical Center, Rehovot, Israel; 3Instituto de Tecnologia Química e Biológica, Oeiras, Portugal; and 4Medigene AG, Martinsried, Germany Division of Clinical and Functional Anatomy, Department of Anatomy, Histology and Embryology (EJP, MJB, MB, MZ, HF), Medical University of Innsbruck, Innsbruck, Austria; Department of Gynaecology and Obstetrics (NC, KK, A-GZ), Medical University of Innsbruck, Innsbruck, Austria; Department of Otolaryngology (JD), Medical University of Innsbruck, Innsbruck, Austria; Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany (PA); Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany (PA) 3Tumor Immunology Program, D010, German Cancer Research Center (DKFZ), Heidelberg, Germany 4Translational Immunology, German Cancer Research Center, Heidelberg, Germany. From the Tumor Immunology Programme, German Cancer Research Center, Heidelberg, Germany; the Department for Internal Medicine B, Kaplan Hospital, Rehovot, Israel; the Division of Oncology, Department for Internal Medicine, Universitätsspital Zürich, Switzerland; and ZMBE, Institut für Zellbiologie, Münster, Germany. 1Clinical Cooperation Unit Dermato-Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; 2Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. 5Tumor Immunology Programme, German Cancer Research Center, Heidelberg, Germany; |
Incoming Links
Total number of triples: 228.